In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Cameron Health brings in $107mm in Series F venture funding

Executive Summary

In one of the largest medical device venture rounds in history, Cameron Health Inc. (subcutaneous implantable defibrillator) has raised $107mm in Series F funding. Alloy Ventures and Delphi Ventures co-led the financing and were joined by all of the company’s previous investors, including Boston Scientific Corp., PTV Sciences, Three Arch Partners, Sorrento Ventures, and Versant Ventures. The money will be used to complete FDA submission in the US and broaden the international marketing of the S-ICD defibrillator system. The company has raised about $300mm to date.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register